Beyer Pat — SEC Form 4 filings
SEC reporting owner CIK 1627985. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-04.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-05 to 2026-06-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 3,000 shares, $204,900 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: purchase of 3,000 shares @ $68.30 ($204,900) in CONMED Corp, filed 2024-05-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CONMED Corp (CNMD) | President & CEO | 6 | 1 leg · 3,000 sh · $204,900 | — | 6 |
| Bioventus Inc. (BVS) | Director | 5 | — | — | 11 |
Form 4 filings — Beyer Pat
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 32,282 @ $0 · Option exercise (M): 32,282 (derivative) @ $0 · Grant/award (A): 25,146 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | CONMED Corp (CNMD) | Grant/award (A): 28,145 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | CONMED Corp (CNMD) | Grant/award (A): 28,800 (derivative) @ $0 · Grant/award (A): 68,258 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 26,493 @ $0 · Option exercise (M): 26,493 (derivative) @ $0 · Grant/award (A): 32,282 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | CONMED Corp (CNMD) | Grant/award (A): 86,355 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 965 @ $0 · Option exercise (M): 965 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Bioventus Inc. (BVS) | Grant/award (A): 26,493 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 30,400 @ $0 · Option exercise (M): 30,400 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | CONMED Corp (CNMD) | Purchase (P): 3,000 @ $68.30 | EDGAR |
| 2024-04-26 | 4 | CONMED Corp (CNMD) | Grant/award (A): 20,060 (derivative) @ $70.01 | EDGAR |
| 2024-03-05 | 4 | CONMED Corp (CNMD) | Grant/award (A): 44,677 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1627985 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →